Cutaneous and Mucocutaneous Leishmaniasis.
Clinical manifestations
Cutaneous leishmaniasis
Diagnosis
Diagnóstico
Leishmaniasis cutánea
Leishmaniasis mucocutánea
Manifestaciones clínicas
Mucocutaneous leishmaniasis
Tratamiento
Treatment
Journal
Actas dermo-sifiliograficas
ISSN: 2173-5778
Titre abrégé: Actas Dermosifiliogr (Engl Ed)
Pays: Spain
ID NLM: 101777537
Informations de publication
Date de publication:
11 May 2021
11 May 2021
Historique:
received:
29
12
2020
accepted:
13
02
2021
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
29
5
2021
Statut:
aheadofprint
Résumé
Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa. The 3 main types of leishmaniasis are cutaneous (the most common), mucocutaneous, and visceral (the most severe). Visceral leishmaniasis is also known as kala-azar. Leishmaniasis is diagnosed by demonstrating the presence of Leishmania amastigotes in clinical specimens using direct microscopic examination or molecular analysis. Various treatments exist, although the evidence supporting the options available for cutaneous leishmaniasis is weak. Both the classical presentation of leishmaniasis and our management of the disease have changed in recent decades because of acquired immune deficiency caused by conditions such as human immunodeficiency infection or the use of tumor necrosis factor inhibitors.
Identifiants
pubmed: 34045157
pii: S1578-2190(21)00171-2
doi: 10.1016/j.adengl.2021.05.011
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Informations de copyright
Copyright © 2021. Published by Elsevier España, S.L.U.